Your browser doesn't support javascript.
loading
Rapid Response to Vedolizumab Therapy in Biologic-Naive Patients With Inflammatory Bowel Diseases.
Feagan, Brian G; Lasch, Karen; Lissoos, Trevor; Cao, Charlie; Wojtowicz, Abigail M; Khalid, Javaria Mona; Colombel, Jean-Frédéric.
Afiliação
  • Feagan BG; Robarts Research Institute, University of Western Ontario, London, Ontario, Canada.
  • Lasch K; Takeda Pharmaceuticals U.S.A., Inc, Deerfield, Illinois.
  • Lissoos T; Takeda Pharmaceuticals U.S.A., Inc, Deerfield, Illinois.
  • Cao C; Takeda Pharmaceuticals U.S.A., Inc, Deerfield, Illinois.
  • Wojtowicz AM; Takeda Pharmaceuticals U.S.A., Inc, Deerfield, Illinois.
  • Khalid JM; Takeda Development Centre Europe, Ltd, London, United Kingdom.
  • Colombel JF; Department of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: jean-frederic.colombel@mssm.edu.
Clin Gastroenterol Hepatol ; 17(1): 130-138.e7, 2019 01.
Article em En | MEDLINE | ID: mdl-29857145

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doenças Inflamatórias Intestinais / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doenças Inflamatórias Intestinais / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article